Endurant Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Hold |
0
| – | – | – | 85 |
|
|
2021
Q3 | – | Sell |
-600,788
| Closed | -$5.83M | – | 71 |
|
|
2021
Q2 | $5.83M | Buy |
600,788
+122,414
| +26% | +$1.19M | 1.6% | 24 |
|
|
2021
Q1 | $5.14M | Sell |
478,374
-177,367
| -27% | -$1.91M | 1.34% | 28 |
|
|
2020
Q4 | $9.65M | Buy |
655,741
+283,340
| +76% | +$4.17M | 3.48% | 4 |
|
|
2020
Q3 | $5.29M | Sell |
372,401
-305,422
| -45% | -$4.34M | 1.57% | 17 |
|
|
2020
Q2 | $5.48M | Buy |
677,823
+200,119
| +42% | +$1.62M | 0.3% | 17 |
|
|
2020
Q1 | $1.93M | Buy |
+477,704
| New | +$1.93M | 0.87% | 30 |
|
|
2016
Q4 | – | Sell |
-24,400
| Closed | -$361K | – | 99 |
|
|
2016
Q3 | $361K | Sell |
24,400
-2,900
| -11% | -$42.9K | 0.13% | 80 |
|
|
2016
Q2 | $245K | Buy |
27,300
+14,800
| +118% | +$133K | 0.08% | 84 |
|
|
2016
Q1 | $116K | Hold |
12,500
| – | – | 0.04% | 86 |
|
|
2015
Q4 | $158K | Buy |
+12,500
| New | +$158K | 0.05% | 77 |
|